Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

207713

Sigma-Aldrich

1,3-Di-o-tolylguanidine

99%

Synonym(s):

DTG

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
(CH3C6H4NH)2C(=NH)
CAS Number:
97-39-2
Molecular Weight:
239.32
EC Number:
202-577-6
MDL number:
MFCD00008513
UNSPSC Code:
12352100
PubChem Substance ID:
24852467
NACRES:
NA.22
Pricing and availability is not currently available.

Quality Level

100

Assay

99%

form

solid

mp

176-178 °C (lit.)

solubility

water: soluble 70 mg/mL at 20 °C

functional group

amine

SMILES string

Cc1ccccc1NC(=N)Nc2ccccc2C

InChI

1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18)

InChI key

OPNUROKCUBTKLF-UHFFFAOYSA-N

Gene Information

human ... EBP(10682)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

1,3-Di-o-tolylguanidine is a selective σ-receptor agonist[1]. 1,3-Di-o-tolylguanidine is σ site ligand and its interaction with dopamine drugs were studied in Wistar rats and Albino Swiss mice[2].

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302

Hazard Classifications

Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCW7506
MKCV7802
MKCW1599
MKCW1600
MKCW8211

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Martina Kovarova et al.
Nature communications, 9(1), 4156-4156 (2018-10-10)
Non-adherence to medication is an important health care problem, especially in the treatment of chronic conditions. Injectable long-acting (LA) formulations of antiretrovirals (ARVs) represent a viable alternative to improve adherence to HIV/AIDS treatment and prevention. However, the LA-ARV formulations currently
Jiping Liu et al.
Polymers, 11(5) (2019-05-16)
Modified nano-TiO2 was prepared by using triethanolamine and tetraisopropyl di (dioctylphosphate) titanate, respectively. Then the poly(p-phenylene benzobisoxazole) (PBO) fibers doped with different additions of modified nano-TiO2 particles were prepared by preparing PBO polymer solution and dry-jet wet spinning technique. Thermogravimetric
Grzegorz Wicher et al.
Journal of neurotrauma, 34(22), 3173-3182 (2017-05-12)
Traumatic brain injury (TBI) is a devastating condition, often leading to life-long consequences for patients. Even though modern neurointensive care has improved functional and cognitive outcomes, efficient pharmacological therapies are still lacking. Targeting peripherally derived, or resident inflammatory, cells that
S A Mousavi et al.
Ultrasonics sonochemistry, 46, 26-35 (2018-05-10)
A nanostructured cationic zinc nitrate complex with a formula of [ZnLNO3]NO3 (where L = (N2E,N2'E)-N1,N1'-(ethane-1,2-diyl)bis(N2-((E)-3-phenylallylidene)ethane-1,2-diamine)) was prepared by sonochemical process and characterized by single crystal X-ray crystallography, scanning electron microscopy (SEM), FT-IR and NMR spectroscopy and X-ray powder diffraction (XRPD). The X-ray
Tomokazu Yoshinaga et al.
Antiviral research, 152, 1-9 (2018-02-08)
Cabotegravir (CAB, S/GSK1265744) is an investigational second-generation integrase strand transfer inhibitor (INSTI) with a chemical structure similar to dolutegravir. CAB is under development as a long-acting injectable formulation for treatment of HIV-1 infection and for pre-exposure prophylaxis. We conducted an
View All Related Papers

Questions

1–3 of 3 Questions  

  1. What is the nature of the biological activity of Product 207713, 1,3-di-o-tolylguanidine?

    1 answer

    1. 1,3-Di-o-tolylguanidine is known to be a selective ligand for the sigma site in the mammalian central nervous system. Behavioral changes, such as hypothermia, reduced pain behavior, circling behavior, and decreased locomotor activity in mice and/or rats were observed after intraperitoneal, subcutaneous, intravenous and/or intranigral injection.

      Helpful?

  2. What is the solubility of Product 207713, 1,3-di-o-tolylguanidine?

    1 answer

    1. 1,3-Di-o-tolylguanidine is soluble in water at 70 micrograms per mL at ambient temperature.

      Helpful?

  3. What is the Department of Transportation shipping information for this product?

    1 answer

    1. Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.

      Helpful?

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service